With increasing awareness about the need to manage obesity—a global epidemic—launch of weight-loss injections in India and public demand for tailored treatment, hospitals in Delhi-NCR are stepping up ...

The former NFL player shared that now that he's lost weight, which was indeed a goal of his, there's one thing that just ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Data from 32 studies concluded that the impact of exercise is modest in terms of meaningful weight loss. Caloric restriction ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Keeping Up With the Kardashians' star Khloé Kardashian has been open about her health journey over the years. Here's ...

Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...